Early Observations on Effects of Mavacamten on Left Atrial Function in Obstructive Hypertrophic Cardiomyopathy Patients – ClinicalKey
Find ” in this , , or Mavacamten is a myosin ATPase inhibitor that leads to symptomatic improvement and reduction of left ventricular (LV) dynamic obstruction in obstructive hypertrophic cardiomyopathy (HCM) patients. However, its effects on left atrial (LA) function a… There was an error loading this content. Please…